Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
09/14/1995 | WO1995024200A1 Method for treating 5ht2b receptor related conditions |
09/14/1995 | WO1995024194A1 Treatment of obsessive-compulsive disorders with 5-ht2 antagonists |
09/14/1995 | WO1995024191A1 8-substituted tetrahydro-beta-carbolines |
09/14/1995 | WO1995024189A1 Increasing fetal hemoglobin levels using carboxylic esters |
09/14/1995 | WO1995024186A1 Sulfonamide derivatives and their use |
09/14/1995 | WO1995024182A1 Human osteoclast-derived cathepsin |
09/14/1995 | CA2443236A1 Human osteoclast-derived cathepsin |
09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
09/14/1995 | CA2185236A1 Method for treating 5ht2b receptor related conditions |
09/14/1995 | CA2185235A1 8-substituted tetrahydro-beta-carbolines |
09/14/1995 | CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
09/14/1995 | CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof |
09/14/1995 | CA2185104A1 Naphthalene derivatives as prostaglandin 12 agonists |
09/14/1995 | CA2184905A1 Corpuscles of stannius protein, stanniocalcin |
09/14/1995 | CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
09/14/1995 | CA2184695A1 Increasing fetal hemoglobin levels using carboxylic esters |
09/14/1995 | CA2184583A1 Transforming growth factor alpha h1 |
09/14/1995 | CA2183961A1 Fibroblast growth factor-10 |
09/14/1995 | CA2183653A1 Sulphonamide derivatives as aspartyl protease inhibitors |
09/14/1995 | CA2183428A1 Sulfonamide derivatives and their use |
09/14/1995 | CA2182800A1 Method of stimulating hematopoiesis with hemoglobin |
09/13/1995 | EP0671409A2 Malonic acid derivatives having anti-adhesive properties |
09/13/1995 | EP0671408A2 Carbohydrate mimetics having anti-adhesive properties |
09/13/1995 | EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors |
09/13/1995 | EP0671406A2 Sulfated beta-glycolipid derivatives as cell adhesion inhibitors |
09/13/1995 | EP0671397A1 Alkylaminoindanes compounds, processes for their preparation and pharmaceutical compositions containing them |
09/13/1995 | EP0671171A1 Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events |
09/13/1995 | EP0671160A1 Use of sulphonic acids as antiageing agents in cosmetic and/or dermatological compositions |
09/13/1995 | EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes |
09/13/1995 | EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
09/13/1995 | EP0670904A1 Vector for the expression of therapy-relevant genes |
09/13/1995 | EP0670898A1 Interleukin-3 (il-3) mutant polypeptides |
09/13/1995 | EP0670839A1 Process for the preparation of 9-amino camptothecin |
09/13/1995 | EP0670826A1 Fatty acid derivatives and pharmaceutical compositions containing them |
09/13/1995 | EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor |
09/13/1995 | EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same |
09/13/1995 | EP0670720A1 Enzyme inhibitors |
09/13/1995 | EP0670719A1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
09/13/1995 | EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
09/13/1995 | EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides |
09/13/1995 | CN1108456A Benzothiazole compound, process for producing the same, and use thereof |
09/13/1995 | CN1108257A Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives |
09/13/1995 | CN1108254A Process for the preparation of alpha-tocopherol derivatives |
09/13/1995 | CN1108247A Compounds |
09/13/1995 | CN1108244A Lactone compound and process of production thereof |
09/13/1995 | CN1108098A Methods of inhibiting alzheimer's disease |
09/13/1995 | CN1108096A Non-peptide tachykinin receptor antagonists |
09/13/1995 | CN1108092A Methods of increasing macrophage function |
09/13/1995 | CN1108090A Methods for inhibiting LDL oxidation and atherosclerosis |
09/12/1995 | US5449798 Phospholipid derivatives containing higher elements of the fifth group |
09/12/1995 | US5449692 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation |
09/12/1995 | US5449674 Prostaglandin E2 inhibitors |
09/12/1995 | US5449661 Angiotensin converting enzyme inhibitor and method for preparing same |
09/12/1995 | US5449522 Antitumor |
09/12/1995 | US5449355 Retrograde tissue splitter and method |
09/12/1995 | US5448898 Air treatment plant for foodstuff comprising a trough with an adjustable width |
09/12/1995 | EP0680318A4 Method for increasing the efficiency of feed conversion in animals. |
09/12/1995 | CA2144390A1 Malonic acid derivatives having antiadhesive properties |
09/12/1995 | CA2144388A1 Carbohydrate mimetics having antiadhesive properties |
09/12/1995 | CA2144288A1 Alkylaminoindans compounds; process for preparing the same and pharmaceutical compositions containing them |
09/12/1995 | CA1336978C Bisphosphonates |
09/12/1995 | CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions |
09/12/1995 | CA1336953C Method of preventing or reducing adverse reactions to protamine using a thromboxane a _receptor antagonist |
09/11/1995 | CA2144019A1 Tetrazolyphenyl pivalate derivatives and medicinal composition containing the same as effective component |
09/08/1995 | WO1995023857A1 Yeast strains and modified albumins |
09/08/1995 | WO1995023790A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives |
09/08/1995 | WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists |
09/08/1995 | WO1995023783A1 Ketopanthenol with acetylating properties |
09/08/1995 | WO1995021927A3 Targeting gene therapy |
09/08/1995 | CA2183752A1 Ketopanthenol with acetylating properties |
09/06/1995 | EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it |
09/06/1995 | EP0670330A1 Long-chain alkylamides of aminoacids and peptides with antiproliferative and antiinflammatory properties |
09/06/1995 | EP0670318A2 Acetamides with analgesic and neuroprotective activity |
09/06/1995 | EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases |
09/06/1995 | EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent |
09/06/1995 | EP0669937A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
09/06/1995 | EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
09/06/1995 | EP0669919A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
09/06/1995 | EP0669914A1 Novel isoxazolines as antiinflammatory agents |
09/06/1995 | EP0669909A1 Substituted amidino compounds, their manufacture and methods of treatment |
09/06/1995 | EP0669830A1 Substituted dipeptide analogs promote release of growth hormone |
09/06/1995 | EP0669827A1 Compositions for the regulation of cytokine activity |
09/06/1995 | EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions. |
09/06/1995 | EP0509027B1 A process to correct and optimize the composition of a feed |
09/06/1995 | EP0478721B1 New benzocycloalkene carboxylic acid and process for producing it |
09/06/1995 | EP0317627B1 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
09/06/1995 | CN1107839A Carbox amide |
09/06/1995 | CN1107704A Methods of inhibiting thrombin |
09/06/1995 | CN1107703A Methods of inhibiting hirsutism and alopecia in women |
09/06/1995 | CN1107700A Melatonin derivatives for use in terating desynchronization disorders |
09/06/1995 | CN1107699A Treatment of incontinence |
09/05/1995 | US5447959 Vitamin A derivatives |
09/05/1995 | US5447954 Antilipidemic agents |
09/05/1995 | US5447951 Use of 3-indolepyruvic acid or its salt |
09/05/1995 | US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis |
09/05/1995 | US5447924 Vitamin D analogues |
09/05/1995 | US5447852 DNA encoding cyclophilin C, and recombinant methods employing it |
09/05/1995 | US5447719 β-glucuronidase inhibitor |
09/05/1995 | CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors |
09/05/1995 | CA2142153A1 Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |